#AC225 - Twitter Hashtag

4 months ago

#NorthStarMedicalRadioisotopes and #QSAGlobal announce agreement to strengthen the #supplychain for #Actinium225, a #radioactive #isotope used in targeted alpha therapies for #cancertreatment. https://t.co/dN13rW1uhu #radiopharma #radiopharmaceuticals #Radium226 #Ac225 #isotopes

0

2

0

142

Lincoln Electric

@LincolnElectric

10 months ago

It’s bittersweet that we retire the AC-225. The machine that shaped careers, built communities, and powered countless projects. Thank you for making it a legend. Visit your local retailer to grab the last AC-225 units today! #AC225 #WeldRed #WeldRedNation

3

6

1

0

369

Ryan Voutilainen 🇨🇦🇫🇮 @RyanVoutilainen

over 1 year ago

Well Calgary… while you’re not in the snowfall warning, I hear at least some accumulations are coming. Last night’s snow pellets on the drive back from Drumheller were enough. Peace out, until next time! #ABwv #ABstorm #AC225 #YYC 🛫 #YVR🛬

RyanVoutilainen's tweet photo. Well Calgary… while you’re not in the snowfall warning, I hear at least some accumulations are coming. Last night’s snow pellets on the drive back from Drumheller were enough. Peace out, until next time!

#ABwv #ABstorm
#AC225 #YYC 🛫 #YVR🛬 https://t.co/4qPEBZf5m6

3

23

0

930

Anil Bidkar @anilbidkar1

over 1 year ago

Exciting news from Flavell Lab(@flavell_rob)! Our latest study on CD46-targeted Actinium-225 alpha particle therapy for disseminated prostate cancer is now online in Clinical Cancer Research. Read it @CCR_AACR: https://t.co/DBMr6nwbLb #ProstateCancer #Ac225 #CD46 #Theranostics

Prostate Cell News

@ProstateCell

over 1 year ago

Dr. @anilbidkar1 and team highlight that [225Ac]Macropa-PEG4-YS5 holds the potential for clinical translation for metastatic #ProstateCancer. 🔗 Check out their study in @CCR_AACR: https://t.co/3GAAMPpaNq

ProstateCell's tweet photo. Dr. @anilbidkar1 and team highlight that [225Ac]Macropa-PEG4-YS5 holds the potential for clinical translation for metastatic #ProstateCancer.

🔗 Check out their study in @CCR_AACR: https://t.co/3GAAMPpaNq https://t.co/YF0MqtuZOB

0

2

0

490

1

7

1

0

381

Fission @FissionChain

over 1 year ago

Bridging the future of nuclear medicine! DYK @Energy_Fuels ' expertise in Th-232 & Ra-226 could align with @NusanoInc 's innovative Ac-225 production for life-saving cancer therapies? 💉🔬 Two Utah powerhouses w/ the potential to redefine isotopes! #NuclearMedicine #Ac225 $UUUU

0

2

0

1

151

Michel Doepke

@doepke_michel

almost 2 years ago

#Radiopharma space never sleeps: Eckert & Ziegler and $TLX Enter into a Collaboration and Licence Agreement for #Actinium-225. #Ac225 #EckertundZiegler #EZAG https://t.co/FfA6SAxZDz

0

2

0

525

NucNet Nuclear News

@NucNetNews

about 2 years ago

🇧🇪Medical Isotopes: Belgium's #PanTera Raises €93 Million To Boost Global #Actinium-225 Production Oversubscribed A Series funding round brings total funds to €134m #Radioisotopes #Ac225 #NuclearMedicine #Belgium https://t.co/lLTcNLfDzi

1

5

0

2

489

Nusano

@NusanoInc

over 2 years ago

Nusano opens radiochemistry laboratory to advance isotope commercialization and customer collaboration. #Lu177 shipments expected to begin early 2025, followed by #Ac225. More: https://t.co/atr3ylsQUg #cancer #radiopharmaceuticals #API

0

3

2

0

265

Update in Nuclear Medicine

@update_in_nm

over 2 years ago

Recently published article in efficacy and safety of Ac-225 PSMA therapy in mCRPC. For more details: https://t.co/ssbS4XrTay #psma #psmatherapy #prostatecancer #ac225

update_in_nm's tweet photo. Recently published article in efficacy and safety of Ac-225 PSMA therapy in mCRPC. For more details: https://t.co/ssbS4XrTay #psma #psmatherapy #prostatecancer #ac225 https://t.co/ICXSFo0bxw

0

17

2

1

782

NucNet Nuclear News

@NucNetNews

over 3 years ago

🇧🇪🇺🇸#Medical isotopes: #PanTera and #TerraPower to cooperate on #Actinium-225 production Belgian and US companies to address supply gap for clinical trials #isotopes #nuclear #nuclearmedicine #ac225 #Cancer https://t.co/KGVSJA0gwv

1

3

2

1

665

Ratio Therapeutics @Ratio_Tx

about 4 years ago

Ratio is focused on optimizing the delivery of #radiation to tumors while simultaneously minimizing uptake by normal tissues with its technology platform #Trillium™. Whilst its #Macropa™ chelate platform takes advantage of the tumor-killing power of the alpha emitter #Ac225.

Ratio_Tx's tweet photo. Ratio is focused on optimizing the delivery of #radiation to tumors while simultaneously minimizing uptake by normal tissues with its technology platform #Trillium™. Whilst its #Macropa™ chelate platform takes advantage of the tumor-killing power of the alpha emitter #Ac225. https://t.co/mEQW9ckLmY

0

2

0

IBA RadioPharma Solutions @IBA_RadioPharma

about 4 years ago

SCK CEN and IBA RadioPharma Solutions pave the way to production of #actinium-225 for patient use. By working towards large-scale production, both partners are helping to make the innovative #cancer therapy widely accessible. https://t.co/HeEX82oZIZ #radiopharmaceuticals #Ac225

IBA_RadioPharma's tweet photo. SCK CEN and IBA RadioPharma Solutions pave the way to production of #actinium-225 for patient use. By working towards large-scale production, both partners are helping to make the innovative #cancer therapy widely accessible. https://t.co/HeEX82oZIZ #radiopharmaceuticals #Ac225 https://t.co/MiZWSuMynH

0

11

4

0

Russo Partners @russopartners

about 4 years ago

Recently on @HealthProRadio, @DrPhilKantoff, CEO of @ConvergentRx, discusses the positive clinical results observed with Convergent’s #radioantibody, CONV01-α, an #Ac225 linked #PSMA-targeted #mAb for the treatment of #prostatecancer. Listen here: https://t.co/PlU9pZjxO6

0

3

2

0

Ratio Therapeutics @Ratio_Tx

over 4 years ago

Today, Ratio announces an agreement with @BEBIG_Group for the joint development and manufacturing of #radiopharmaceutical products based on the isotopes #Lu177 and #Ac225. This partnership will support our current clinical programs for #cancer. Read more: https://t.co/QApBCD940k

Ratio_Tx's tweet photo. Today, Ratio announces an agreement with @BEBIG_Group for the joint development and manufacturing of #radiopharmaceutical products based on the isotopes #Lu177 and #Ac225. This partnership will support our current clinical programs for #cancer.
Read more: https://t.co/QApBCD940k https://t.co/B7bOL23LIL

0

2

0

Convergent Therapeutics, Inc. @ConvergentRx

over 4 years ago

Convergent and @IonetixCorp today announced a long-term supply agreement for the #radioisotope actinium-225. This will support our pipeline of next-gen #radiotherapies and lead candidate CONV01-α, a #PSMA-targeted #mAb linked to #Ac225. Read here: https://t.co/DEEtkHTmb4

ConvergentRx's tweet photo. Convergent and @IonetixCorp today announced a long-term supply agreement for the #radioisotope actinium-225. This will support our pipeline of next-gen #radiotherapies and lead candidate CONV01-α, a #PSMA-targeted #mAb linked to #Ac225.

Read here: https://t.co/DEEtkHTmb4 https://t.co/07XpaXK9gI

0

4

1

0

Convergent Therapeutics, Inc. @ConvergentRx

over 4 years ago

#DYK that targeted #radiopharmaceuticals can deliver effective #radiation doses to tumor sites regardless of how many or where they are in the body? We have developed a targeted #radioantibody by combining the radioisotope #Ac225 with a mAb. Learn more: https://t.co/D7gF2Fgeyl

ConvergentRx's tweet photo. #DYK that targeted #radiopharmaceuticals can deliver effective #radiation doses to tumor sites regardless of how many or where they are in the body? We have developed a targeted #radioantibody by combining the radioisotope #Ac225 with a mAb.

Learn more: https://t.co/D7gF2Fgeyl https://t.co/j9J25ctfoD

0

1

0

ORNL Isotopes @ORNLIsotopes

over 4 years ago

Excited to share with local media in an upcoming story how @ORNL is producing #actinium-225 for #cancer therapy. In studies, #Ac225 shows promise for #targeting cancer cells with minimal effect on surrounding, healthy cells.

ORNLIsotopes's tweet photo. Excited to share with local media in an upcoming story how @ORNL is producing #actinium-225 for #cancer therapy. In studies, #Ac225 shows promise for #targeting cancer cells with minimal effect on surrounding, healthy cells. https://t.co/GNfkL2IRyW

0

12

2

0

Biotech @ej23ny

about 5 years ago

$ATNM very excited about this trial #ASH20 results: Phase 1/2 #Lintuzumab #Ac225 + #CLAGM in AML patients N=15 ORR 73% CR 67% #ASH21 Phase 1 Topline data N=18/21 Dose 1.0 μCi/kg/ 1.25 μCi/kg

0

11

2

0

Tom Podolec Aviation @TomPodolec

about 5 years ago

Update ARFF CALL ✈️ 🚒 🚨 Air Canada #AC225 from Calgary to Vancouver declared an emergency for fumes in the aircraft. Landed runway 08L. Emergency services inspected; all good now. Aircraft taxiing to gate. ARFF following. https://t.co/f63t6k12ry